Rather, SPHK1-deficient T cells showed a sustained memory response and reduced differentiation to Tregs independent of S1PR signaling, which resulted in activity of T cells against murine melanoma cells and synergy with ICB [133]. The gene discussed is SPHK1; the disease is melanoma.